These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9873769)
1. Haemophilia care within the United Kingdom. Ludlam CA Haemophilia; 1998 Jul; 4(4):427-8. PubMed ID: 9873769 [No Abstract] [Full Text] [Related]
2. Current concepts in the management of hemophilia. Karayalcin G Pediatr Ann; 1985 Sep; 14(9):640-2, 644-5, 648-53 passim. PubMed ID: 3932946 [No Abstract] [Full Text] [Related]
3. Haemophilia and haemorrhagic disorders. Stevens R Practitioner; 1993 Apr; 237(1525):350-4. PubMed ID: 8351278 [No Abstract] [Full Text] [Related]
4. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom. Rizza CR; Spooner RJ Br Med J (Clin Res Ed); 1983 Mar; 286(6369):929-33. PubMed ID: 6403138 [TBL] [Abstract][Full Text] [Related]
5. Progress and problems in hemophilia and von Willebrand's disease. Abildgaard CF Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429 [No Abstract] [Full Text] [Related]
6. [Hemophilia. New aspects in diagnosis and treatment]. Gormsen J Ugeskr Laeger; 1973 Nov; 135(46):2487-93. PubMed ID: 4592776 [No Abstract] [Full Text] [Related]
7. Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand disease. Kreuz W; Klarmann D; Auerswald G; Auberger K; Gürtler L; Rabenau H; Doerr WD Lancet; 1993 Feb; 341(8842):446. PubMed ID: 8094219 [No Abstract] [Full Text] [Related]
8. [Oral administration of factor VIII or IX concentrate preparation]. Sakuragawa N Rinsho Ketsueki; 1985 Jul; 26(7):1086-9. PubMed ID: 3932721 [No Abstract] [Full Text] [Related]
9. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada. CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466 [TBL] [Abstract][Full Text] [Related]
10. Haemophilia treatment in the United Kingdom from 1969 to 1974. Biggs R Br J Haematol; 1977 Apr; 35(4):487-504. PubMed ID: 871406 [TBL] [Abstract][Full Text] [Related]
12. [Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia]. Guerois C; Parquet A; Vicariot M; Lecoeur FF; Maisonneuve P; Courouce AM; Dubois F; Laurian Y Presse Med; 1991 Jun; 20(25):1163-6. PubMed ID: 1830653 [TBL] [Abstract][Full Text] [Related]
14. Human plasma von Willebrand factor/factor VIII complex (Haemate P/Humate-P) in von Willebrand disease and haemophilia A: a viewpoint by Eric Berntorp. Berntorp E Drugs; 2007; 67(10):1520. PubMed ID: 17600396 [No Abstract] [Full Text] [Related]
15. [Emergency therapy and ambulatory care in hemophilia]. Remde W Z Gesamte Inn Med; 1979 Jun; 34(12):154-6. PubMed ID: 315673 [No Abstract] [Full Text] [Related]
16. Treatment of single factor deficiencies: a case study approach. Marques MB Clin Lab Sci; 2003; 16(2):120-2. PubMed ID: 12757193 [No Abstract] [Full Text] [Related]
17. Distinguishing mild hemophilia A from von Willebrand's syndrome. Sabo MG; Triplett DA; Peden JC Am J Med Technol; 1978 May; 44(5):455-63. PubMed ID: 307909 [No Abstract] [Full Text] [Related]
18. The management of patients with bleeding disorders. Wyld PJ; Dawson KP N Z Med J; 1984 Feb; 97(750):118-9. PubMed ID: 6424072 [No Abstract] [Full Text] [Related]
19. Treatment protocol of haemophilia and other congenital bleeding disorders in Italy. Italian Association of Hemophilia Centers (AICE). Gringeri A Haemophilia; 1998 Jul; 4(4):423-4. PubMed ID: 9873767 [No Abstract] [Full Text] [Related]